Shining a Light on the Invisible Struggle: National Diabetes Awareness Month Highlights the Resilience of the Type 1 Diabetes Community

Type 1 diabetes remains one of the most widely misunderstood and frequently underestimated chronic health conditions affecting millions globally. Often hidden beneath the surface of a seemingly healthy exterior, the daily reality of managing type 1 diabetes (T1D) involves an unrelenting, round-the-clock balancing act of monitoring blood glucose levels, calculating carbohydrate intake, and administering precise doses of insulin. Despite these profound daily challenges, the global T1D community—comprising patients, caregivers, researchers, and advocates—is working tirelessly to foster visibility, accelerate life-changing research, and drive forward progress toward a future where type 1 becomes type none.

In recognition of National Diabetes Awareness Month (NDAM), organizations such as Breakthrough T1D are stepping up efforts to share the personal narratives of those most intimately affected by the condition. By bringing these stories to light, advocates aim to dismantle common public misconceptions, reduce the social stigma often associated with chronic illness, and build a robust network of shared understanding and support. Whether through elite athletic achievement, scientific innovation, or grassroots community-building, the voices of the T1D community illustrate both the trials of the condition and the remarkable resilience of those who live with it every day.

The Daily Reality and Unpredictability of T1D

Living with type 1 diabetes requires an acute, constant awareness of physiological variables that most people never have to consider. Unlike type 2 diabetes, which is frequently associated with insulin resistance and lifestyle factors, type 1 diabetes is an autoimmune condition in which the body’s immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Consequently, individuals with T1D produce little to no insulin and must rely on exogenous insulin delivery—either via multiple daily injections or an automated insulin pump—alongside continuous glucose monitors (CGMs) to survive.

However, medical technology, while vastly improved, is not a cure. Managing the condition involves navigating a complex matrix of biological and environmental factors. As Yousra Omer, a Senior Coordinator of Health Policy at Breakthrough T1D who lives with T1D, points out, predictability is rarely guaranteed.

"Part of managing diabetes is trying to expect the unexpected; everything impacts T1D, from food to stress to exercise to sleep," Omer explains. "Even if I do the exact same things every single day, my blood sugars would still be different, which doesn’t mean I am doing something wrong."

This sentiment resonates deeply across the patient community, where the psychological toll of chronic self-management is frequently compounded by the invisible nature of the disease. Friends, colleagues, and employers often fail to grasp the cognitive load carried by a person with T1D, who must mentally calculate insulin-to-carbohydrate ratios, account for unexpected physical activity, and manage the jarring symptoms of both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) while maintaining ordinary daily responsibilities.

From Professional Athletics to Cutting-Edge Research: Inspiring T1D Journeys

Despite these formidable hurdles, individuals with type 1 diabetes continue to excel at the highest levels of professional sports, academic research, and public advocacy, shattering outdated stereotypes about what people with chronic illnesses can achieve.

Among those redefining the boundaries of physical capability is Mason Miller, a relief pitcher for Major League Baseball’s San Diego Padres. Diagnosed with T1D when he was 20 years old, Miller faced the daunting task of adjusting to a life-altering medical condition while simultaneously navigating the grueling athletic demands of ascending the ranks of professional baseball.

"When I was diagnosed [with T1D], I was struggling as a D3 pitcher and now I’m pitching in the MLB for the Padres," Miller shares. "A lot of hard work accompanied getting healthy and educated, but I do feel grateful for the technology that allows me to take such good care of myself."

Miller’s success serves as a powerful testament to the advancements in modern diabetes management technology. Decades ago, elite athletic competition with T1D carried exponentially higher risks due to the limitations of fingerstick blood glucose testing and delayed insulin absorption rates. Today, real-time continuous glucose monitors provide athletes with instant data feeds directly to their smartwatches or mobile devices, enabling them to make immediate adjustments during high-stress competition.

On the scientific front, researchers who live with the condition are bringing a unique, firsthand perspective to the laboratory. Dr. Camillo Bechi Genzano, a Breakthrough T1D-funded researcher exploring disease-modifying therapies while managing his own T1D diagnosis, recalls a markedly different era of healthcare.

"I was diagnosed with type 1 diabetes when I was 12. Life back then was pretty hard," Dr. Bechi Genzano says. "I remember all the struggles before continuous glucose monitors and insulin pumps, and the life of people with this disease has dramatically improved over the past few years, and it’s going to improve further as we go."

Dr. Bechi Genzano’s dual role as both a patient and a medical researcher underscores the urgency driving the scientific community. Investigators who experience the daily burdens of T1D firsthand are uniquely positioned to direct research toward meaningful clinical endpoints that prioritize not just glycemic control, but the ultimate eradication of the disease through immune-modulating therapies and cell-replacement technologies.

The Power of Community and Early Support

While adult patients and researchers navigate the professional and scientific landscapes of T1D, children newly diagnosed with the condition face a distinct set of emotional and social adjustments. For families with no prior history of diabetes, a pediatric diagnosis can feel isolating and overwhelming.

Alyssa Burns, a participant in the Breakthrough T1D Walk and mother to 10-year-old Carter, who lives with T1D, emphasizes the critical importance of community outreach and peer connection for young children.

"I wanted to get Carter involved with meeting other people who have type 1 diabetes because we have nobody," Burns explains. "He doesn’t know anybody with type 1, we have no family members. I thought it’d be good for him to get himself out there [at Walk], meet some other kids, and show him that he’s not alone in this."

Initiatives such as community walks, family support groups, and youth camps play an indispensable role in mitigating the psychological isolation that frequently accompanies a pediatric chronic illness diagnosis. By connecting children with peers who check their blood sugar, change their infusion sets, and manage lows without hesitation, organizations like Breakthrough T1D help normalize the condition and build lifelong coping mechanisms.

Embracing the Journey: Balancing Joy and Adversity

Managing a lifelong, incurable condition requires a delicate psychological balance between diligence and self-compassion. Jessie Stover, Development Manager of the Breakthrough T1D Indiana Chapter, who has lived with T1D since she was two years old, offers practical and compassionate advice for navigating the emotional complexities of the disease.

"Celebrate your diaversary, bedazzle your Omnipod, rock your fun patterned tapes, celebrate with diabesties," Stover advises. "Find little ways to bring joy into it, but also take the time to feel the bad days. Take the time to learn how to let the good and bad coexist."

Stover’s perspective highlights the modern philosophy of diabetes care, which increasingly emphasizes mental health and emotional well-being alongside traditional glycemic metrics like HbA1c levels. By encouraging patients to embrace the cultural elements of the diabetes community—such as customized device stickers and anniversary celebrations—advocates are helping to transform medical equipment from symbols of restriction into expressions of personal identity.

Broader Impacts, Historical Context, and Future Outlook

The observance of National Diabetes Awareness Month arrives at a pivotal juncture in the history of diabetes care. Over the past century, the management of type 1 diabetes has undergone a series of revolutionary transformations. Following the historic discovery of insulin in 1921 by Frederick Banting and Charles Best at the University of Toronto—a breakthrough that turned a universally fatal diagnosis into a manageable condition—generations of scientists have continuously refined insulin formulations and delivery mechanisms.

In recent decades, the advent of continuous glucose monitoring systems, hybrid closed-loop automated insulin delivery systems (often referred to as "artificial pancreas" technology), and emerging immunotherapies designed to delay or halt the autoimmune destruction of beta cells have fundamentally altered the landscape of care. In 2022, the U.S. Food and Drug Administration (FDA) approved teplizumab, the first disease-modifying therapy capable of delaying the onset of stage 3 type 1 diabetes in individuals with stage 2 disease, marking a monumental shift toward early intervention and prevention.

Despite these extraordinary scientific strides, significant systemic challenges remain. The rising cost of insulin and advanced medical devices continues to impose a severe financial burden on patients and healthcare systems worldwide. Advocacy organizations like Breakthrough T1D play an essential role in lobbying legislative bodies for price caps, expanded insurance coverage, and streamlined regulatory pathways for next-generation therapeutics. Furthermore, public awareness campaigns are vital for ensuring that symptoms of T1D—such as excessive thirst, frequent urination, unexplained weight loss, and fatigue—are recognized early by educators, pediatricians, and families to prevent life-threatening complications like diabetic ketoacidosis (DKA) at the time of diagnosis.

Looking Forward: Amplifying Every Voice

As National Diabetes Awareness Month continues to shine a spotlight on the condition, advocacy groups emphasize that the momentum behind research, advocacy, and community support relies entirely on the active participation of individuals willing to share their lived experiences.

Living with type 1 diabetes looks different for every single person who carries the diagnosis. Whether managing the condition in the high-pressure environment of professional sports, conducting laboratory research to find a cure, or navigating the daily uncertainties of childhood and school, every story contributes to a broader cultural understanding of the disease. By sharing the highs, the lows, the hard-won triumphs, and the moments of community connection, individuals with T1D are helping to move the world closer to life-changing breakthroughs and, ultimately, a future where type 1 becomes type none.